BD Ups R&D Spending, Focusing On Drug Delivery And Diabetes Research
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson is investing in research on the use of micro-needles and needleless technologies in advanced drug delivery systems
You may also be interested in...
BD’s R&D Pipeline Includes Micro-Needle Drug Delivery; Q4 Sales Up 8%
BD is preparing for functionality testing of its development-stage Micro Infuser wearable drug-delivery system, incorporating micro-needles to deliver drugs just below the skin's surface to minimize pain
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.